TWIST1 and breast cancer: A recent meta‐analysis showed a positive correlation between expression of EMT‐TFs (SNAIL1, SNAIL2, and TWIST1) and 3‐year overall survival in 3218 patients with advanced breast cancer (HR 1.72, 95% CI = 1.53–1.93) (Imani et al., 2016).